You just read:

Janssen Submits New Drug Application to U.S. Food and Drug Administration for the First Darunavir-Based Single Tablet Regimen for the Treatment of HIV-1

News provided by

Janssen Research & Development, LLC

Sep 25, 2017, 08:00 ET